Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The health science subsidiary of the food giant Nestlé has invested $65 million in Seres Health, a Cambridge, Mass.-based firm that is developing biological drugs designed to treat disease by restoring a malfunctioning microbiome. Seres recently raised $48 million from other investors. Seres says it will use the funds to move its lead product, SER-109, into Phase III clinical trials for preventing the recurrence of Clostridium difficile infection.
This article has been sent to the following recipient: